Sight Sciences, Inc.
18
1
2
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
33.3%
6 terminated/withdrawn out of 18 trials
60.0%
-26.5% vs industry average
6%
1 trials in Phase 3/4
144%
13 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (18)
A Study of the Helix Surgical System in Primary Open-Angle Glaucoma (POAG) and Cataract (HELIX)
Role: lead
TearCare MGX™ System With and Without Warming Hold
Role: lead
TearCare in Young Adults
Role: collaborator
OMNI 3.1 Surgical System in Subjects With Primary Open-Angle Glaucoma
Role: lead
Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA)
Role: lead
Safety and Effectiveness of the Sight Sciences VISCO™360 Versus SLT in Primary Open Angle Glaucoma
Role: lead
Pilot Study of TearCare System - Long-Term Extension
Role: lead
Study of OMNI Surgical System and iStent for Eyes With OAG (Trident)
Role: lead
A Pilot Study of the TearCare System in Adults With Dry Eye Disease
Role: lead
TearCare System to Treat Dry Eye Disease
Role: lead
Randomized Study of the Safety and Effectiveness of the TearCare System for the Signs and Symptoms of Dry Eye Disease
Role: lead
Study of the TearCare System in Dry Eye Disease
Role: lead
An Observational Multicenter Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System In Pseudophakic Eyes With Primary Open Angle Glaucoma (ORION 2.0)
Role: lead
A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Patients With Primary Open Angle Glaucoma
Role: lead
A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System
Role: lead
Study of OMNI System in OAG (GEMINI)
Role: lead
A Post-market Study Of Use Of The OMNI® Surgical System In Open Angle Glaucoma
Role: lead
A Prospective, Multicenter Study of the OMNI® Surgical System in Pseudophakic Eyes With Open Angle Glaucoma
Role: lead
All 18 trials loaded